Literature DB >> 10969462

Persistent measles virus infection as a possible cause of otosclerosis: state of the art.

H P Niedermeyer1, W Arnold, W J Neubert, R Sedlmeier.   

Abstract

The etiopathogenesis of otosclerosis is still largely unexplained and remains controversial. Morphologic examinations have shown the presence of a chronic inflammation in otosclerotic tissue. Among the proposed explanations for this inflammation are an immunologic reaction against collagen, mutations of collagen gene 1A1, and a viral infection. In this paper, we focus on the role of measles virus in otosclerosis, and we review the current literature, devoting particular attention to a suspected paramyxoviral etiopathogenesis in Paget's disease. Our examination of footplate fragments by reverse transcription polymerase chain reaction testing in 95 patients with otosclerosis revealed the presence of measles virus RNA in 83% of cases. Quantification of measles virus immunoglobulin G (IgG) in otosclerosis patients indicated that the ratio of antimeasles virus IgG in total IgG was higher in perilymph than in serum. Furthermore, an almost identical incidence of otosclerosis and measles virus-caused mortality in women suggests that women are more susceptible to measles virus infection. Finally, since the introduction of the measles virus vaccination program in Europe, there has been a decline in the incidence of otosclerosis. Moreover, the average age of patients at diagnosis and surgery at our hospital has increased to 54 years. Our findings, when they are considered along with findings regarding the presence of paramyxoviral RNA in Paget's disease, support the hypothesis that measles virus is involved in the etiopathogenesis of otosclerosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10969462

Source DB:  PubMed          Journal:  Ear Nose Throat J        ISSN: 0145-5613            Impact factor:   1.697


  9 in total

Review 1.  Within host RNA virus persistence: mechanisms and consequences.

Authors:  Richard E Randall; Diane E Griffin
Journal:  Curr Opin Virol       Date:  2017-03-17       Impact factor: 7.090

2.  Osteoprotegerin expression and sensitivity in otosclerosis with different histological activity.

Authors:  Tamás Karosi; Péter Csomor; Anita Szalmás; József Kónya; Mihály Petkó; István Sziklai
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-10-21       Impact factor: 2.503

3.  The influence of measles vaccination on the incidence of otosclerosis in Germany.

Authors:  Wolfgang Arnold; Raymonde Busch; Andreas Arnold; Björn Ritscher; Albrecht Neiss; Hans Peter Niedermeyer
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-02-13       Impact factor: 2.503

Review 4.  Perspectives of pharmacological treatment in otosclerosis.

Authors:  Balázs Liktor; Zoltán Szekanecz; Tamás József Batta; István Sziklai; Tamás Karosi
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-07-29       Impact factor: 2.503

Review 5.  An overview of the etiology of otosclerosis.

Authors:  Konstantinos Markou; John Goudakos
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-08-13       Impact factor: 2.503

6.  Long-term hearing results of stapedotomy: analysis of factors affecting outcome.

Authors:  Ingeborg Dhooge; Stéphanie Desmedt; Thomas Maly; David Loose; Helen Van Hoecke
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-02-16       Impact factor: 2.503

7.  The Stapes in Otosclerosis: Osteoarthritis of an Ear Ossicle.

Authors:  Anna-Lee Clarke-Brodber; Jerome B Taxy
Journal:  Head Neck Pathol       Date:  2021-01-07

8.  Expression of TNF-α, OPG, IL-1β and the presence of the measles virus RNA in the stapes of the patients with otosclerosis.

Authors:  Małgorzata Potocka-Bakłażec; Monika Sakowicz-Burkiewicz; Jerzy Kuczkowski; Tadeusz Pawełczyk; Czesław Stankiewicz; Wojciech Sierszeń; Zbigniew Jankowski; Jacek Buczny
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-03-28       Impact factor: 2.503

9.  The Rise and Fall of Otosclerosis: A Population-based Study of Disease Incidence Spanning 70 Years.

Authors:  John P Marinelli; Douglas J Totten; Kiran K Chauhan; Christine M Lohse; Brandon R Grossardt; Jeffrey T Vrabec; Matthew L Carlson
Journal:  Otol Neurotol       Date:  2020-10       Impact factor: 2.619

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.